Carcinoma of the Head and Neck

Oncology·MeSH: Vulvar Neoplasms

13 drugs in development·7 companies·0 clinical trials

Drug Pipeline by Phase

Phase 3(5)

Phase 2(1)

Drug	Company
cylembio	IO Biotech, Inc. (IOBT)

Phase 1(6)

Drug	Company
CIML NK cell Infusion	FATE THERAPEUTICS INC (FATE)
CIML NK cell Infusion	Amneal Pharmaceuticals, Inc. (AMRX)
gen-011	GENOCEA BIOSCIENCES, INC. (GNCA)
Interleukin-15 Superagonist	FATE THERAPEUTICS INC (FATE)
Interleukin-15 Superagonist	Amneal Pharmaceuticals, Inc. (AMRX)
sl-279252	Shattuck Labs, Inc. (STTK)

Phase 4(1)

Drug	Company
Monalizumab	ASTRAZENECA PLC (AZN)

Full trial data, competitive analysis, and AI-powered pipeline tracking.